Kind Inc. — Dark Chocolate Nuts & Sea Salt Bars, Dark Chocolate Nuts & Sea Salt
by KIND Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Kind Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 9 MRT-tested substances, including major food allergens and multiple whole food triggers. The presence of ‘natural flavor’ poses an additional risk of hidden triggers. Due to the high volume of reactive substances, this product is categorized as HIGH_RISK and is not suitable for Phase 1 or Phase 2 of the LEAP protocol.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 9
- Safe Ingredients: 3
- Unknown/Ambiguous: 1 (natural flavor)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| almonds | Almond | Direct Match |
| peanuts | Peanut | Direct Match |
| honey | Honey | Direct Match |
| sugar | Cane Sugar | Direct Match |
| glucose syrup | Corn | Derived Match |
| rice flour | Rice | Direct Match |
| unsweetened chocolate | Cocoa | Direct Match |
| alkalized cocoa | Cocoa | Direct Match |
| soy lecithin | Lecithin (Soy) | Direct Match |
| soy lecithin | Soybean | Derived Match |
| cocoa butter | Cocoa | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: natural flavor. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 9 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 602652270284
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Tree nut tested individually on the MRT panel. Almond flour and almond milk are common substitutes in elimination diets — verify your personal MRT results before using.
Peanut is a legume (not a tree nut) tested on the MRT panel. Peanut oil, peanut butter, and peanut flour are all included. Distinct from IgE peanut allergy testing.
Honey is tested as a distinct substance on the MRT panel. It contains proteins that can trigger mediator release independently of its sugar content. Found in many "natural" sweetened products.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Corn derivatives are among the hardest triggers to avoid. Found as corn syrup, cornstarch, modified food starch, dextrose, maltodextrin, and citric acid in thousands of processed products.
Rice is often used as a "safe" base in elimination diets, but some patients do react to it. Verify with your MRT results before assuming rice is safe for your Phase 1 rotation.
Cocoa (Theobroma cacao) is tested as a standalone substance. Reactivity to cocoa affects all chocolate-containing products. Distinct from dairy or sugar reactions that often co-occur in chocolate.
Soy lecithin is one of the most ubiquitous food additives, used as an emulsifier in chocolate, baked goods, and margarine. Even small amounts can trigger mediator release in sensitive patients.
Soy-derived ingredients appear in a wide range of processed foods including soy lecithin, soybean oil, and textured soy protein. One of the most prevalent hidden triggers.
What This Means For Your Diet
With 9 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 9 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from KIND Inc.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners